RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice
Authors
Keywords
Bariatric surgery, Roux-en-Y gastric bypass, Pharmacokinetics, Oral absorption, Drug disposition, Therapeutic drug monitoring
Journal
OBESITY SURGERY
Volume 27, Issue 4, Pages 1076-1090
Publisher
Springer Nature
Online
2017-01-26
DOI
10.1007/s11695-016-2535-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study
- (2016) Lieke Mitrov-Winkelmolen et al. OBESITY SURGERY
- Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations
- (2015) Ina Gesquiere et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Altered Drug Disposition Following Bariatric Surgery: A Research Challenge
- (2015) H. Karl Greenblatt et al. CLINICAL PHARMACOKINETICS
- How fast and how often: The pharmacokinetics of drug use are decisive in addiction
- (2015) Florence Allain et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery
- (2015) Margreke J. Brill et al. PHARMACEUTICAL RESEARCH
- Comparison of Warfarin Dosages and International Normalized Ratios Before and After Roux-en-Y Gastric Bypass Surgery
- (2015) Kristine J. Steffen et al. PHARMACOTHERAPY
- Proximal Roux-en-Y Gastric Bypass Alters Drug Absorption Pattern But Not Systemic Exposure of CYP3A4 and P-glycoprotein Substrates
- (2015) Lingtak-Neander Chan et al. PHARMACOTHERAPY
- Decreased Escitalopram Concentrations Post–Roux-en-Y Gastric Bypass Surgery
- (2015) Mark A. Marzinke et al. THERAPEUTIC DRUG MONITORING
- G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm Res 12, 413–420, 1995—Backstory of BCS
- (2014) Vinod P. Shah et al. AAPS Journal
- Review article: the nutritional and pharmacological consequences of obesity surgery
- (2014) J. Stein et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of a Roux-en-Y Gastric Bypass on the Pharmacokinetics of Oral Morphine Using a Population Approach
- (2014) Célia Lloret-Linares et al. CLINICAL PHARMACOKINETICS
- The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC
- (2014) Yasuhiro Tsume et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Evolution of Metabolic/Bariatric Surgery
- (2014) Henry Buchwald OBESITY SURGERY
- Moxifloxacin dosing in post-bariatric surgery patients
- (2013) Pieter Colin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Influence of Bypass Procedures and Other Anatomical Changes in the Gastrointestinal Tract on the Oral Bioavailability of Drugs
- (2013) Julie De Smet et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Comparison of Duloxetine Plasma Levels in Postbariatric Surgery Patients Versus Matched Nonsurgical Control Subjects
- (2013) James L. Roerig et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery
- (2013) L. Sjöström JOURNAL OF INTERNAL MEDICINE
- Oral Liquid l-Thyroxine (l-T4) May Be Better Absorbed Compared to l-T4 Tablets Following Bariatric Surgery
- (2013) Ilenia Pirola et al. OBESITY SURGERY
- Assessment of Warfarin Dosing Requirements After Bariatric Surgery in Patients Requiring Long-Term Warfarin Therapy
- (2013) Adriane N. Irwin et al. PHARMACOTHERAPY
- Blood alcohol concentrations rise rapidly and dramatically after Roux-en-Y gastric bypass
- (2013) Kristine J. Steffen et al. Surgery for Obesity and Related Diseases
- The Effectiveness and Risks of Bariatric Surgery
- (2013) Su-Hsin Chang et al. JAMA Surgery
- The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors
- (2012) Giselle G. Hamad et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients
- (2012) Sweta Tandra et al. ANNALS OF SURGERY
- The effects of gastric bypass surgery on drug absorption and pharmacokinetics
- (2012) Dion R Brocks et al. Expert Opinion on Drug Metabolism & Toxicology
- Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?
- (2012) R. Hamilton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effect of gastric bypass surgery on azithromycin oral bioavailability
- (2012) R. S. Padwal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution
- (2012) Adam S. Darwich et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Changes in the Makeup of Bariatric Surgery: A National Increase in Use of Laparoscopic Sleeve Gastrectomy
- (2012) Ninh T. Nguyen et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin
- (2012) Gunn Signe Jakobsen et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Improved Levothyroxine Pharmacokinetics After Bariatric Surgery
- (2012) Margarita Gkotsina et al. THYROID
- Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin
- (2011) R. S. Padwal et al. DIABETES CARE
- Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery
- (2011) J. De Smet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Levothyroxine Absorption in Morbidly Obese Patients Before and After Roux-En-Y Gastric Bypass (RYGB) Surgery
- (2011) Ileana Gabriela Sanchez Rubio et al. OBESITY SURGERY
- Superior calcium bioavailability of effervescent potassium calcium citrate over tablet formulation of calcium citrate after Roux-en-Y gastric bypass
- (2011) Khashayar Sakhaee et al. Surgery for Obesity and Related Diseases
- Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort
- (2010) James L. Roerig et al. Surgery for Obesity and Related Diseases
- Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs
- (2009) Arik Dahan et al. AAPS Journal
- Significantly Altered Systemic Exposure to Atorvastatin Acid Following Gastric Bypass Surgery in Morbidly Obese Patients
- (2009) I B Skottheim et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A systematic review of drug absorption following bariatric surgery and its theoretical implications
- (2009) R. Padwal et al. Obesity Reviews
- Comparison of the Absorption of Calcium Carbonate and Calcium Citrate after Roux-en-Y Gastric Bypass
- (2009) P. Tondapu et al. OBESITY SURGERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started